Introduction
In healthy subjects, the level of glucose in plasma is tightly controlled by hormones, such as insulin, glucagon, epinephrine, growth hormone, and glucagon-like peptide, which ensure that glycemia remains in a physiological range (~80-150 mg/dl) despite external perturbations, such as meals and physical activity. In particular, insulin is a hormone secreted by pancreatic β cells when plasma glucose increases, which stimulates glucose uptake by insulin-dependent tissues (mainly muscles and adipose tissues) and inhibits hepatic glucose production. Conversely, in type 1 diabetic patients, endogenous insulin secretion is lacking and is usually replaced by exogenous injections/infusions of insulin analogues. This intensive insulin treatment is helpful in maintaining nearly normal levels of glycemia and thus reducing chronic complications markedly; however, it may cause a risk of potentially dangerous severe hypoglycemia, which has been identified as the primary barrier to optimal diabetes management. 1 Thanks to new developments in glucose sensor technology and subcutaneous insulin pumps, recently the research effort has focused on the development of closed loop glycemic control, the so-called artificial pancreas. For instance, recent studies investigated the performances of proportional-integral-derivative 2, 3 and model predictive control (MPC) algorithms, 4, 5 with both in vivo and in silico trials. The role of in silico testing of closed loop glucose control algorithms is of major importance and has been recently recognized also by the Food and Drug Administration (FDA). In fact, in January 2008, a computer simulator of type 1 diabetes developed by our group was accepted by the FDA as a substitute to animal trials for the preclinical testing of control strategies in artificial pancreas studies. 6 This simulator is based on a model of the glucose-insulin system in the postprandial state. 7, 8 The novelty of this model was that it was validated not only on plasma glucose and insulin concentrations, but also by fitting the major metabolic fluxes (endogenous glucose production, meal rate of appearance, glucose utilization, and insulin secretion) estimated in a modelindependent way in a wide population. However, while meal perturbations are satisfactorily taken into account in the model, 9 a description of the effect of physical activity is lacking. However, adapting insulin delivery during physical activity is difficult and may cause hypoglycemic events. Thus, the inability to describe the effect of physical activity on glucose metabolism is considered one of the major obstacles to the development of an artificial pancreas usable in normal life conditions. Conversely, the ability to simulate this phenomenon would be of great help in designing control algorithms, especially those based on MPC.
The objective of this study was thus to incorporate in the simulator a model of the exercise effect on insulindependent glucose uptake. To do that, since adequate data are not available at the moment, we implemented in the simulator some accepted notions of the effect of exercise on glucose utilization based on published quantitative and qualitative analysis. Exercise has been shown to augment the availability of glucose transporter-4 (GLUT-4), both by translocation to the cell membrane [10] [11] [12] and by increased transcription in muscle cells. 13, 14 These changes have been shown to be associated with an increase in insulin sensitivity and insulin-independent glucose uptake. 12, [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] The pathways of exercise-induced translocation and augmented transcription are not entirely elucidated yet, but muscle fibers contractions have been proven to be at the source of these changes. 16 As far as an exercise model is concerned, a description of these cellular events at a macrolevel is not available; in the past, the action of exercise on glucose metabolism has been described indirectly as a rise in insulin. 17 As shown in the literature, the parameters of the minimal model of glucose kinetics can change significantly during and after physical activity. [23] [24] [25] These changes, consequent to the vascular and metabolic adaptations to increased energy utilization and storage described earlier, render the minimal model impossible to use during exercise without a precise description of the amplitude and dynamics of these changes. Moreover, in a closed loop perspective, the timing of exercise is not known, making any real-time use difficult. In a previous publication, 24 the authors showed that changes in the minimal model dynamics as a consequence of mild to moderate exercise can be described in two phases: a transient change in insulin-independent glucose clearance and a longer term change in insulin sensitivity, confirming and expanding the work of Derouich and Boutayeb 25 with clinical data. A parsimonious exercise model has been proposed that provides a mechanistic description of this phenomenon, aiming to link the change in insulin action and glucose effectiveness to HR. 18 Starting from the latter publication, we proposed and tested three extensions of Breton 18 and included them into our type 1 diabetes meal model. The reliability of the different descriptions is judged by comparing model predictions during a euglycemic-hyperinsulinemic in silico trial, with different intensities and durations of exercise.
Having selected the best model, we also show further simulations of glucose profiles during physical activity performed at fasting and 3 hours after a meal.
It has, however, to be emphasized that the current lack of experimental data precludes the possibility to definitively assess model validity at this stage. Thus, further studies are needed to validate and improve the proposed model of physical activity. However, the present study demonstrated the capability of the glucose-insulin simulator to be adapted easily to normal life conditions.
The Meal Glucose-Insulin Model of Type 1 Diabetes at Rest
The model describing the glucose-insulin control system during a meal in type 1 diabetes is shown in Figure 1 . This section provides a brief overview of the whole model (for details, see Dalla Man and associates 7, 8, 19 ), while a detailed description of glucose utilization is given due to its relevance in physical activity.
The model is made up of a glucose and an insulin subsystem linked by the control of insulin on glucose utilization and endogenous production. The glucose subsystem consists of a two-compartment model of glucose kinetics. The insulin subsystem also consists of two compartments, the first representing the liver and the second the plasma. The most important model unit processes are endogenous glucose production, glucose rate of appearance, and glucose utilization. Suppression of endogenous glucose production is assumed to be linearly dependent on plasma glucose concentration, portal insulin concentration, and a remote insulin signal. Key parameters are hepatic glucose effectiveness (glucose control on endogenous glucose production suppression) and hepatic insulin sensitivity (insulin control on endogenous glucose production suppression). Glucose intestinal absorption describes the glucose transit through the stomach and intestine by assuming that the stomach is represented by two compartments (one for the solid and one for the triturated phase), while a single compartment is used to describe the gut; the rate constant of gastric emptying is a nonlinear function of the amount of glucose in the stomach. Glucose utilization during a meal is made up of two components: insulin-independent utilization takes place in the first compartment, is constant, and represents glucose uptake by the brain and erythrocytes (F cns ):
,
whereas insulin-dependent utilization occurs in the remote compartment, which represents peripheral tissues and depends nonlinearly, i.e., via Michaelis-Menten kinetics, on glucose in tissues 20, 21 ( Figure 2 
where G t (mg/kg) is glucose mass in the remote compartment and V m is assumed to be linearly dependent on a remote, i.e., interstitial fluid, insulin,
where X (pmol/liter) represents remote insulin described by ,
where I is plasma insulin, suffix b denotes basal state, and p 2U (min -1 ) is the rate constant of insulin action on peripheral glucose utilization.
Total glucose utilization, U, is thus .
In order to simulate type 1 diabetes subjects, a subcutaneous insulin infusion module was also added to simulate insulin transit from the subcutaneous space to plasma. 8, 19 It is important to note that, at this point in time, this model of glucose-insulin system does not consider diurnal variations of insulin sensitivity (represented here by parameter V mx ) or other parameters. This is of course a limitation of the model; however, no data with the depth needed to inform such a model are available to support this hypothesis on possible parameter time courses.
A Model of Physical Activity
We built on a recent parsimonious exercise model that links the change in insulin action and glucose effectiveness to HR. 18 The model assumes that the instantaneous HR correlates well with the duration and intensity of physical activity. 22 The following three extensions of the model proposed in Breton 18 have been considered and tested.
Model A
Paralleling Breton, 18 Equation (2) is modified as follows:
, (6) where X follows Equation (4) and Y and Z are given by
with .
In other words, Y is a delayed version of the overbasal HR signal and Z is controlled via a nonlinear differential equation mainly driven by f(Y). Therefore, insulin-independent glucose clearance raises in the few minutes following the onset of exercise as observed in Breton et al. 24 f(Y) is constructed so that it is negligible until Y reaches a certain fraction of basal HR (controlled by parameter a), corresponding to exercise onset. Thereafter, f(Y) reaches 1 very rapidly (speed is dependent on both a and n) and drives Z upward, in effect mimicking a quick activation of available GLUT-4 transporters (transfer of vesicular GLUT-4 to the membrane) and thus an increase in insulin sensitivity. After exercise, f(Y) resumes negligible values, allowing Z to fall back slowly via a quasi-exponential decay driven by T ex ; this allows the model to follow literature findings of enhanced insulin sensitivity for up to 22 hours after an exercise bout. In summary, V m0 ⋅ β ⋅ Y represents the rapid on-and-off increase in insulin-independent glucose clearance and V mx ⋅ α ⋅ Z represents the rapid-on/slow-off effect of exercise on insulin sensitivity.
Model B
Alternative models were tested to evaluate the impact of model assumptions on the predicted effect of physical activity on glucose homeostasis. For instance, compared with model A, model B assumes first that the rapid on-and-off change in basal glucose clearance is absent. Then, it also assumes that the rapid-on/slow-off change in insulin sensitivity depends not only on the increase in the steady-state value of the Michaelis-Menten glucose utilization [V mx ⋅ (1 + α ⋅ Z)], but is also due to an enhanced rate of increase of glucose utilization (i.e., K m is lowered in proportion to insulin action:
where X, Y, and Z follow Equations (4), (7), and (8), respectively.
Model C
Because different levels of exercise (and thus of HR) have the same effect on glucose utilization with model B while the difference is negligible with model A (see Results), we have introduced model C, which assumes that insulin action is increased in proportion to the duration and intensity of exercise, i.e., to the area under the curve of HR-HR b . Insulin-dependent utilization becomes ,
where X, Y, and Z follow Equations (4), (7), and (8), respectively, and ,
where t z is the time at which Z(t) comes back to zero (i.e., t z = 3 ⋅ T ex ). W is thus related to both duration and intensity of exercise (Figure 3) . Figure 4 shows the time course of variables Y, Z, and W in response to a squarewave variation of HR. It is worth noting that in real life the heart rate may increase with several patterns, e.g., in a linear fashion; here a step increase in HR is assumed in order to better illustrate model behavior. Figure 5 shows how variables Y, Z, and W influence insulindependent glucose utilization.
Model parameters are set to values reported in Breton. 18 They are reported in Table 1 . 
In Silico Experiments
One hundred parameter vectors were generated randomly from the joint parameter distribution, available in the type 1 diabetic population (accepted by the FDA). Each parameter vector corresponds to an in silico subject. Thus, 100 type 1 diabetic in silico subjects were simulated under several experimental conditions. A constant basal insulin infusion was administered to all subjects to guarantee that basal glucose was maintained in absence of a meal or intravenous perturbation. Basal HR was assumed to be 70 beats per minute (bpm) for all subjects. Each in silico subject underwent the following three protocols.
1. Euglycemic-hyperinsulinemic clamp plus exercise: the basal insulin infusion rate was increased by 40% at t = 60 minutes; the glucose infusion rate was changed in order to maintain a constant glucose concentration. At t = 300 minutes, each subject exercised for 15 and 30 minutes at mild (mild 15 and mild 30 ) or moderate (mod 15 and mod 30 ) intensity. Mild exercise is defined as physical activity corresponding to an increase of 50% of the basal heart rate (HR = 1.5 ⋅ HR b ), corresponding to about 90 bpm; moderate exercise is defined as physical activity corresponding to an increase of 100% of the basal heart rate (HR = 2 ⋅ HR b ), corresponding to approximately 120 bpm. 
Results

Comparison of Exercise Models
The reliability of the presented models was assessed by considering model predictions during the euglycemichyperinsulinemic clamp (Figure 6 ).
Model B predicts that different levels of exercise (and thus of HR) have the same effect on glucose utilization, whereas this difference is negligible with model A. Conversely, model C predicts a reasonable glucose infusion rate during the euglycemic-hyperinsulinemic clamp. In fact, from the simulations, the increment in insulin action is similar for 15 minutes of moderate exercise and 30 minutes of mild exercise, both higher than the increment due to 15 minutes of mild exercise and lower than the increment due to 30 minutes of moderate exercise. Model C was thus selected as the best among the three presented models.
In Silico Experiments
Possible experiments, usable to validate the model, or possible scenarios to test closed loop insulin infusion algorithms included physical activity alone or physical activity coupled with a euglycemic-hyperinsulinemic clamp or a meal. Results obtained with model C in 100 in silico subjects in the three simulated experiments are described next.
Euglycemic-Hyperinsulinemic Clamp Plus Exercise. The average glucose infusion rate needed to maintain constant glucose during this experiment for different durations and vigorousness of physical activity is shown Figure 6 , bottom. The area under the glucose infusion rate was mild 15 = 2524 ± 144 (mean ± SE), mild 30 = 2744 ± 157, mod 15 = 2741 ± 157, and mod 30 = 3176 ± 183 mg/kg, and the difference was statistically significant (p < 0.01) for all comparisons apart from mild 30 vs mod 15 .
Exercise Only. The average glucose concentration for different durations and vigorousness of physical activity is shown in Figure 7 , top. The suppression of glucose concentration (calculated as the difference between the area under basal glucose and the area under the glucose curve) was mild 15 = 10,428 ± 903 (mean ± SE), mild 30 = 20,050 ± 1653, mod 15 = 19,937 ± 1646, and mod 30 = 36,299 ± 2720 mg/dl⋅min, and the difference was statistically significant (p < 0.01) for all comparisons apart from mild 30 vs mod 15 .
Meal Plus Exercise. The average glucose concentration during this experiment for different durations and vigorousness of physical activity is shown in Figure 7 , bottom. The area under glucose concentration was mild 15 = 227,011 ± 3021 (mean ± SE), mild 30 = 218,940 ± 3278, mod 15 = 218,849 ± 3279, and mod 30 = 205,516 ± 3650 mg/dl⋅min, and the difference was statistically significant (p < 0.01) for all comparisons apart from mild 30 vs mod 15 .
Conclusions
The ability to predict the effect of exercise on glucose disposal in type 1 diabetes could be very helpful, as adaptation of insulin infusion during physical activity is one of the major obstacles to the development of an artificial pancreas working in normal life conditions. The availability of a simulator able to reproduce daily life as much as possible is of great help in testing closed loop control algorithms, especially those based on MPC. 4, 5 This study incorporated an extension of a parsimonious model of physical activity proposed in Breton 18 into a simulation model of a glucose-insulin system 7, 8, 19 Such a model is based on the idea that HR is a good, and easy to measure, marker of physical activity. Three different models have been considered and tested in simulation. Model A assumes that exercise causes a rapid on-andoff increase in insulin-independent glucose clearance and a rapid-on/slow-off effect on insulin sensitivity. Model B relaxes the assumption that exercise causes a rapid on-and-off increase in insulin-independent glucose clearance. Finally, model C is similar to model A but also assumes that insulin action is increased in proportion to the duration and intensity of exercise, i.e., to the area under the curve of HR-HR b .
The quality of the three models was assessed by considering model predictions during euglycemic-hyperinsulinemic clamp simulations (Figure 6 ). Models A and B predict that different levels of exercise (and thus of HR) have basically the same effect on glucose utilization. Conversely, model C predicts a reasonable glucose infusion rate during euglycemic-hyperinsulinemic clamp simulations. In fact, the increment in insulin action is similar for 15 minutes of moderate and 30 minutes of mild exercise, both higher than the increment due to 15 minutes of mild exercise and lower than the increment due to 30 minutes of moderate exercise. Reasonable time courses are also obtained with model C when simulating glucose profiles during physical activity performed at fasting and 3 hours after a meal (Figure 7) .
Given the lack of data supporting model assumptions/ predictions, it very difficult at this stage to draw conclusions based on model predictions and comparison. Nonetheless, albeit margins of improvements are present, the proposed model is, to the best of our knowledge, the first attempt to describe in a quantitative way the relationship between physical activity and change in a crucial parameter such as insulin sensitivity. It thus represents a step forward to simulate normal daily life accurately. Moreover, use of a HR signal as an external input makes the model potentially usable for predicting glucose change during physical activity in vivo and could be very useful in both testing and developing closed loop control algorithms. However, further studies are needed to validate this model against data; in particular, in vivo experiments similar to the in silico protocols described in this article are needed, both in normal and in type 1 diabetic subjects. 
